Prenatol-M

Manufacturer
PureTek Corporation
Effective date
2024-05-06
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 21:03:05

Label at a glance#

ProductPrenatol-M
Active ingredientCHOLECALCIFEROL, FERROUS FUMARATE, MOLYBDENUM, ASCORBIC ACID, ZINC OXIDE, CHOLINE BITARTRATE, RIBOFLAVIN, MAGNESIUM OXIDE, .ALPHA.-TOCOPHEROL ACETATE, DL-, VITAMIN A ACETATE, SELENIUM, NIACINAMIDE, PYRIDOXINE HYDROCHLORIDE, CALCIUM CARBONATE, CHROMIUM NICOTINATE, MANGANESE SULFATE, POTASSIUM IODIDE, METHYLCOBALAMIN, LEVOMEFOLATE CALCIUM, THIAMINE MONONITRATE
Label structure13 sections

Indications and uses

Indications and Usage: Prenatol-M™ is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years. Prenatol-M™ may be beneficial in improving the nutritional status of women prior to conception.

Dosage and administration

Prenatol-M™ caplet daily, between meals or as directed by a licensed healthcare practitioner. Do not administer to children under the age of 12.

Storage and handling

Do not use if bottle seal is broken. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN. Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

Label contents#

Full prescribing information#

DESCRIPTION:

DESCRIPTION SECTION

Each caplet contains:
Vitamin A (as Retinyl Acetate) ………………....… 1500 mcg RAE
Vitamin C (as Ascorbic Acid) ………………….………… 120 mg
Vitamin D3 (as Cholecalciferol).……………....... 20 mcg (800 IU)
Vitamin E (as Dl-Alpha Tocopheryl Acetate) ….......….…. 13.5 mg
Thiamin (as Thiamine Mononitrate) …………...…………… 3 mg
Riboflavin ……………………….…………………….…. 3.4 mg
Niacin (as Niacinamide) ………………..……………….… 20 mg
Vitamin B6 (as Pyridoxine Hydrochloride) …....…………... 50 mg
Folate (as L-5-Methyltetrahydrofolate calcium salt) ….... 2040 mcg DFE
(1200 mcg as L-5-Methylfolate)
Vitamin B12 (as Methylcobalamin) ……….……………... 10 mcg
Choline (as Choline Bitartrate) …….……………………… 55 mg
Calcium (as Calcium Carbonate) ……...…………………. 200 mg
Iron (as Ferrous Fumarate) ………..……………………… 27 mg
Iodine (as Potassium Iodine) …...……………………….150 mcg
Magnesium (as Magnesium Oxide) …...………………… 200 mg
Zinc (as Zinc Oxide) ………………...…………………….. 25 mg
Selenium (as Selenium Amino Acid Chelate) ……………. 70 mcg
Manganese (as Manganese Sulfate) ……………………… 2.6 mg
Chromium (as Chromium Polynicotinate) ……………….. 45 mcg
Molybdenum (as Molybdenum Amino Acid Chelate)…...… 50 mcg

Other Ingredients:

SPL UNCLASSIFIED SECTION

Croscarmellose Sodium, Crospovidone, Magnesium Stearate, Microcrystalline Cellulose, Silicon Dioxide, Stearic Acid, Coating: Hydroxypropyl Methylcellulose [HPMC], PEG-8.

Indications and Usage: Prenatol-M™

INDICATIONS & USAGE SECTION

Indications and Usage: Prenatol-M™ is indicated to provide vitamins and minerals to women throughout pregnancy and during the postnatal period for both lactating and non-lactating mothers, and throughout the childbearing years.

Prenatol-M™ may be beneficial in improving the nutritional status of women prior to conception.

Contraindications:

CONTRAINDICATIONS SECTION

This product is contraindicated in patients with known hypersensitivity to any of its ingredients; also, all iron compounds are contraindicated in patients with hemosiderosis, hemochromatosis, or hemolytic anemias. Pernicious anemia is a contraindication, as folate may obscure its signs and symptoms.

Warnings:

WARNINGS SECTION

Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. In case of accidental overdose, call a doctor or poison control center immediately. Administration of folate alone is improper therapy for pernicious anemia and other megaloblastic anemias in which vitamin B12 is deficient.

Precautions:

PRECAUTIONS SECTION

Folate in doses above 0.1 mg daily may obscure pernicious anemia, in that hematologic remission can occur while neurological manifestations remain progressive. There is a potential danger in administering folate to patients with undiagnosed anemia since folic acid may obscure the diagnosis of pernicious anemia by alleviating the hematologic manifestations of the disease while allowing the neurologic complications to progress. This may result in severe nervous system damage before the correct diagnosis is made. Adequate doses of vitamin B12 may prevent, halt, or improve the neurologic changes caused by pernicious anemia. The patient’s medical conditions and consumption of other drugs, herbs, and/or supplements should be considered.

For use on the order of a licensed healthcare practitioner. Call your doctor about side effects. To report side effects, call PureTek
Corporation
at 1-877-921-7873 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.

Drug Interactions:

DRUG INTERACTIONS SECTION

Prenatol-M™ is not recommended for and should not be given to patients receiving levodopa because the action of levodopa is antagonized by pyridoxine. There is a possibility of increased bleeding due to pyridoxine interaction with anticoagulants (e.g., Aspirin, Heparin, or Clopidogrel).

Adverse Reactions:

ADVERSE REACTIONS SECTION

Folate: Allergic sensitizations have been reported following both oral and parenteral administration of folate.

Ferrous Fumarate: Gastrointestinal disturbances (anorexia, nausea, diarrhea, constipation) occur occasionally but are usually mild and may subside with continuation of therapy. Although the absorption of iron is best when taken between meals, giving Prenatol-M™ after meals may control occasional gastrointestinal disturbances. Prenatol-M™ is best absorbed when taken at bedtime.

Adverse reactions have been reported with specific vitamins and minerals but generally at levels substantially higher than those contained herein. However, allergic, and idiosyncratic reactions are possible at lower levels. Iron, even at the usual recommended levels, has been associated with gastrointestinal intolerance in some patients.

Overdose:

OVERDOSAGE SECTION

Iron: signs and symptoms: Iron is toxic. Acute overdosage of iron may cause nausea and vomiting and, in severe cases, cardiovascular collapse and death. Other symptoms include pallor and cyanosis,melena, shock, drowsiness and coma. The estimated overdose of orally ingested iron is 300 mg/kg body weight. When overdoses are ingested by children, severe reactions, including fatalities, have resulted. Prenatol-M™ should be stored beyond the reach of children to prevent against accidental iron poisoning. Keep this and all other drugs out of the reach of children.

Treatment:

SPL UNCLASSIFIED SECTION

For specific therapy, exchange transfusion and chelating agents should be used. For general management, gastric lavage with sodium bicarbonate solution or milk. Administer intravenous fluids and electrolytes and use oxygen.

Dosage and Administration:

DOSAGE & ADMINISTRATION SECTION

Prenatol-M™ caplet daily, between meals or as directed by a licensed healthcare practitioner. Do not administer to children under
the age of 12.

How Supplied:

HOW SUPPLIED SECTION

Prenatol-M™ are beige speckled, oblong, coated caplets, supplied in a bottle containing 30 caplets (NDC 59088-009-54). Dispense in a tight, light-resistant container as defined in the USP/NF with a child resistant closure.

Storage

STORAGE AND HANDLING SECTION

Do not use if bottle seal is broken.
KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature].

Prenatol-M™

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Manufactured in the USA by:

PureTek Corporation
Panorama City, CA 91402
For questions or information
call toll-free: 877-921-7873

LabelLabel

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
ASCORBIC ACID Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
CALCIUM CATION Pharmacologic Class Indexing3Indexing - Pharmacologic Class20230427
CHOLECALCIFEROL Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
LEVOMEFOLIC ACID Pharmacologic Class Indexing1Indexing - Pharmacologic Class20230428
MAGNESIUM CATION Pharmacologic Class Indexing4Indexing - Pharmacologic Class20180813
MANGANESE CATION (2+) Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
PYRIDOXINE Pharmacologic Class Indexing1Indexing - Pharmacologic Class20170310
VITAMIN A Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
6e3c022f-0786-43f1-8857-edff89d5153fProduct name120260309
86fffa7b-d382-4771-a253-25cccb64b590Product name320251124
95250459-30e4-45c1-b08a-993044f49109Product name220250805
015efbe7-5dcf-c8dc-f62d-817d23b49060Product name220250717
cf050ccd-1144-f76a-e00d-e5698d8597d4Product name620250625
bee4fa8d-8d82-423a-a0b5-40a89dd13a99Product name120250618
e0d2eb29-08bd-4bba-90d1-c91c68a38767Product name420250516
30b0ac6e-02aa-0e5c-0d8b-cffdf3a282b2Product name520250304
59361619-24d9-b610-eca6-5a7f25ed5e03Product name520240909
334fe8d2-68fb-4331-a576-420e302ec069Product name720240320
efd58652-cb8f-4018-91ca-4b0eb2ff729fProduct name720240226
362d7abb-94e6-4c60-9a58-266894157713Product name120231023
e2db08c6-133f-4f4f-afb4-e90a2418d6f6Product name120230320
6bd95106-a412-1dad-b9cc-4cb74bfb27ceProduct name220230315
0306390c-dd77-4363-afe0-63c58088b2a1Product name120220120
503ea967-4b9c-48cf-9e87-c7975295849dProduct name220220120
9badc7be-250a-44ab-aa36-926af3f02679Product name120210527
2641ccb3-721d-4fbf-9f2f-ca2f18157a62Product name320210309
444b3e50-f226-46ef-bfca-2e7035d140cdProduct name120190611
e92765c1-be81-432a-b909-1b10777ec378Product name120190208
11ed6f83-cdd2-4637-8379-b1a1d3ae3cdeProduct name120181101
ddff2484-d547-4e6a-bacd-95eef7e31c64Product name220180807
7cda52fc-125f-421c-8fea-bc1974370c49Product name220180703
90854981-3820-4bc4-a1d3-666ec508941cProduct name220180214
86c45a79-b9f0-4476-a27c-6e10db098497Product name120180125
c5cd4727-ac49-4409-82b1-5bd8006c3ec7Product name120171122
26acd337-b838-40ac-bcbc-05c3b81c8712Product name120170323
5e18e798-5614-cf5c-0185-38b1cb77a093Product name220160822
d5e51f11-ad28-caa4-4b49-4143974782adProduct name120150831
290f523a-f9db-9774-b5a9-e1f908ac1782Product name120150828
e7e58cd3-cacb-49df-8d34-1ee335614abbProduct name120150609
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324
0441a8f5-3835-497c-aedd-bc78cba56b2aProduct name120150317
60c52429-fcef-eb54-2387-43bc9e4f296bProduct name120140508
87711080-88eb-65c5-b2dd-bf99e700a372Product name120140508
c6b65c52-69c7-df49-550a-a50c137f6218Product name120140508
ec2149b3-5c6d-5344-f757-c86411073075Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59088-009-54Prenatol-M30 in 1 BOTTLETABLET301

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59088-009PRENATOL-M (MULTIVITAMIN) TABLET [PURETEK CORPORATION]1Current NDC, 1 package rows20240509_17559a44-94b7-9ca0-e063-6294a90a2123.zip

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
59088-009-54EA - Each59088-0095e8e79f3-e366-4f25-a27d-9800b000abf212024-06-10

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 2 · 43 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59088-00959088-009-54

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 28 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Prenatol-MMULTIVITAMINPureTek Corporation17559a44-94b7-9ca0-e063-6294a90a21232024-05-06Warnings, Adverse reactionsExact identifier
ndc (package): 59088-009-54
ndc (product): 59088-009
ndc11 (package): 59088000954
spl id: 17559a44-94b8-9ca0-e063-6294a90a2123
spl set id: 17559a44-94b7-9ca0-e063-6294a90a2123

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.